ABSTRACT
Bangladesh, one of the top fish producers in the world, has rapidly been expanding its annual fish production. However, the COVID-19 pandemic and related preventative measures have had a substantial impact on the nation's fishing sector. In this study, a survey was performed in the Brahmanbaria subdistrict of Bangladesh to assess the impact of COVID-19 and the subsequent efforts made by the Department of Fisheries (DoF), Bangladesh, to mitigate the negative impact on the culture and capture fisheries. The socioeconomic profile of fishery stakeholders for the years 2019, 2020, and 2021 was used to assess the impact of the COVID-19 pandemic situation on fish farming, fish hatcheries, fish nurseries, the fish feed industry, and the dry fish industry. Data analysis showed that the COVID-19 pandemic had a negative impact on the income of fishery stakeholders and their livelihoods. The income of fish farmers decreased by 47.49% in 2020 as compared to the base year of 2019 but increased by 129.34% in 2021, showing the effects of COVID-19 and mitigation efforts. Transport and movement restrictions adversely affected the culture fisheries while favouring capture fisheries with an increased annual catch. To counter or reduce most of those issues, the DoF, Bangladesh, took necessary steps, such as constructing a virtual control room and engaging the fishermen in some unique activities. Fishermen and other stakeholders benefitted because of farm visits, online training, improved interdepartmental coordination, monitoring of fish-selling marketing channels, activation of the FIAC (Farmer's Information and Advice Centre), and women's engagement through the provision of subsidies and loans. The DoF constructed fish sanctuaries and implemented law enforcement in 2020 and 2021 to safeguard the habitat for small indigenous species (SIS). These actions might have improved the stakeholders' income and the post-pandemic scenario by increasing fish productivity. However, further study is recommended on the effective mitigation measures for drawing a clear conclusion.
ABSTRACT
We report a patient with seronegative rheumatoid arthritis diagnosed with Whipple's disease following treatment of tumour necrosis factor inhibitor (TNFI) therapy. Whipple's disease should be considered in patients with seronegative rheumatoid arthritis and other unexplained multisystem illness. The TNFI therapy and immunosuppressive therapies can unmask latent Whipple's disease.